Dyslipidaemia, hypercoagulability and the metabolic syndrome.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Vascular Pharmacology

• Publication date

  2006-06-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/157016106777698432PMID 16842135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Impact of Physical Exercise on Platelets: Focus on Its Effects in Metabolic Chronic Diseases

  2023cites this paper
• A Cohort Study on Lung Cavitations in Severely Ill COVID-19 Patients – Evidence for a Thromboembolic Pathogenesis.

  2021cites this paper
• Evidence for a thromboembolic pathogenesis of lung cavitations in severely ill COVID-19 patients

  2021cites this paper
• Normas

  2020cites this paper
• Influence of Cardiometabolic Risk Factors on Platelet Function

  2020cites this paper
• Hypertriglyceridemia is associated with platelet hyperactivation in metabolic syndrome patients

  2020cites this paper
• Effect of the consumption of a synbiotic diet mousse containing Lactobacillus acidophilus La-5 by individuals with metabolic syndrome: A randomized controlled trial

  2018cites this paper
• Synbiotic aerated dessert: diet product development and evaluation of the intake effects in individuals with metabolic syndrome

  2017cites this paper
• The Influence of Combined Oral Contraceptive on Erythrocyte Sedimentation Rate , Total Protein , Albumin , Globulin and Fibrinogen in Women *

  2016cites this paper
• Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome

  2016cites this paper
• The current role of thiazolidinediones in diabetes management

  2016cites this paper
• Prevalence of Metabolic Syndrome in Schizophrenic Patients

  2015cites this paper
• Apolipoprotein polymorphism is associated with pro-thrombotic profile in non-demented dyslipidemic subjects

  2015cites this paper
• Clopidogrel resistance response in patients with coronary artery disease and metabolic syndrome: the role of hyperglycemia and obesity

  2015cites this paper
• Inflammation and atherosclerosis

  2014cites this paper
• Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.

  2014cites this paper
• VISFATIN AND CARDIOVASCULAR PROTECTION

  2014cites this paper
• Síndrome metabólico y riesgo cardiovascular en mujeres posmenopáusicas de una institución de primer nivel de Envigado (Colombia)

  2014cites this paper
• Menopausia y su relación con el síndrome metabólico

  2013cites this paper
• Maternal high-fat diet impacts endothelial function in nonhuman primate offspring

  2012cites this paper
• The Prothrombotic Tendency in Metabolic Syndrome: Focus on the Potential Mechanisms Involved in Impaired Haemostasis and Fibrinolytic Balance

  2012influential citation
• Metabolic syndrome in rheumatoid arthritis.

  2012cites this paper
• Elevated body mass index and risk of postoperative CSF leak following transsphenoidal surgery.

  2012cites this paper
• Comparison of two diet and exercise approaches on weight loss and health outcomes in women

  2012cites this paper
• Interrelations entre les différents indices d'adiposité et le tissu adipeux viscéral à la suite d'un programme de modification des habitudes alimentaires et d'activité physique chez des hommes dyslipidémiques avec obésité abdominale

  2012cites this paper
• Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome

  2012cites this paper
• Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment

  2011influential citation
• Репродуктивная функция у мужчин с болезнью Иценко-Кушинга

  2010cites this paper
• Un caso di aspirino-resistenza probabilmente legata alla variabilità glicemica

  2010cites this paper
• Associations of Thrombotic-Hemostatic Factors with Cardiovascular Disease~!2009-10-29~!2009-12-22~!2010-04-08~!

  2010cites this paper
• Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells

  2010cites this paper
• Should adipokines be considered in the choice of the treatment of obesity-related health problems?

  2010cites this paper
• Disturbances in the hemostatic system of patients with endogenous hypercorticism and metabolic syndrome

  2010influential citation
• How safe is the use of thiazolidinediones in clinical practice?

  2009cites this paper
• Disruption of the Nitric Oxide Signaling System in Diabetes

  2009cites this paper
• Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.

  2009cites this paper
• Utility of aspirin therapy in patients with the cardiometabolic syndrome and diabetes.

  2009cites this paper
• Do we need to consider inflammatory markers when we treat atherosclerotic disease?

  2008cites this paper
• Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study

  2008cites this paper
• Oxidative Stress As A Common Mediator for Apoptosis Induced-Cardiac Damage in Diabetic Rats

  2008cites this paper
• The role of fibrinogen and fibrinolysis in peripheral arterial disease.

  2008cites this paper
• Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients

  2008cites this paper
• Pleiotropic effects of thiazolidinediones

  2008cites this paper
• Do Different Vascular Risk Factors Affect All Arteries Equally?

  2008cites this paper
• Characteristics of Urban Sidewalks/Streets and Objectively Measured Physical Activity

  2008cites this paper
• Does diabetes mellitus play a role in restenosis and patency rates following lower extremity peripheral arterial revascularization? A critical overview.

  2008cites this paper
• Le diabète joue-t-il un rôle dans les resténoses et les taux de perméabilité après revascularisation artérielle des membres inferieurs ? une étude générale critique

  2008cites this paper
• ¿Qué papel desempeña la diabetes mellitus en las tasas de reestenosis y permeabilidad tras la revascularización infrainginal? Revisión crítica

  2008cites this paper
• Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles

  2007cites this paper
• Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation.

  2007cites this paper
• Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?

  2007cites this paper
• The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

  2007influential citation
• Human visceral adipose tissue and the plasminogen activator inhibitor type 1

  2007cites this paper
• Beneficial effects of omega-3 fatty acids: the current evidence.

  2006cites this paper